Fidelity Investments’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Fidelity Investments’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-792	Closed	-$438	–	5767
2024 Q4	$438	Sell	792 -1,647	-68%	-$1.3K	﹤0.01%	5000
2024 Q3	$2.39K	Sell	2,439 -5,806	-70%	-$6.22K	﹤0.01%	4773
2024 Q2	$10.1K	Buy	8,245 +5,183	+169%	+$8.84K	﹤0.01%	4332
2024 Q1	$11.6K	Sell	3,062 -3,688	-55%	-$6.93K	﹤0.01%	4221
2023 Q4	$4.46K	Buy	6,750 +5,766	+586%	+$7.91K	﹤0.01%	4484
2023 Q3	$3.84K	Buy	984 +833	+552%	+$3.83K	﹤0.01%	4390
2023 Q2	$908	Buy	+151	New	+$885	﹤0.01%	4724

Other funds holding OCEA

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

RWP

Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments's OCEA Position: Q1 2025 in Review

Fidelity Investments sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2025, closing a stake of 792 shares — an estimated $438 sold.

Fidelity Investments first reported a position in OCEA in Q2 2023 and held it in 7 quarters. The position peaked at $11.6K in Q1 2024. 25 funds tracked by Wall St. Rank hold OCEA as of Q1 2025.

Fidelity Investments reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Fidelity Investments sold 792 Ocean Biomedical, Inc. Common Stock shares in Q1 2025, an estimated $438.
Fidelity Investments first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 7 quarters.
Fidelity Investments's Ocean Biomedical, Inc. Common Stock position peaked at $11.6K in Q1 2024.
25 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.